Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL49376

CCCCOC(=O)C(CCCC)(CCCC)CCCC.N

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.50
ATM Q13315 1/20 0.47
TSHR P16473 5/20 0.44
HPGD P15428 1/20 0.44
CYP4F2 P78329 1/20 0.43
CYP4A11 Q02928 1/20 0.43
HCAR2 Q8TDS4 1/20 0.41
NAAA Q02083 1/20 0.41
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
EPHX1 P07099 1/20 0.38
ESR1 P03372 2/20 0.38
LMNA P02545 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
MAPK1 P28482 1/20 0.38
CYP2C19 P33261 1/20 0.38
NR1H2 P55055 1/20 0.38
RNASEL Q05823 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL28229612 1.00 ALDH1A1 (0.50) ALDH1A1ATMTSHRHPGDCYP4F2
SCHEMBL597342 0.98 ALDH1A1 (0.52) ALDH1A1ATMTSHRHPGDCYP4F2
Ammonia Solution, Strong SCHEMBL28085862 0.96 ALDH1A1 (0.47) ALDH1A1ATMTSHRHPGDCYP4F2
SCHEMBL28854637 0.96 ALDH1A1 (0.50) ALDH1A1ATMTSHRHPGDCYP4F2
Phosphine SCHEMBL27516320 0.96 ALDH1A1 (0.50) ALDH1A1ATMTSHRHPGDCYP4F2
SCHEMBL29159721 0.96 ALDH1A1 (0.50) ALDH1A1ATMTSHRHPGDCYP4F2
Ammonia Solution, Strong SCHEMBL27957643 0.94 NAAA (0.46) ALDH1A1ATMTSHRHPGDCYP4F2
Tetramethylammonium Ion SCHEMBL27675566 0.93 ALDH1A1 (0.44) ALDH1A1ATMTSHRHPGDCYP4F2
SCHEMBL28774030 0.92 NAAA (0.47) ALDH1A1ATMTSHRHPGDCYP4F2
SCHEMBL28490929 0.92 NAAA (0.47) ALDH1A1ATMTSHRHPGDCYP4F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1805 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122037136-A Preparation method of polyisocyanate curing agent 万华化学集团股份有限公司 2026-05-15 CN claimed
WO-2026101967-A1 SYNTHESIS OF RENEWABLE TEREPHTHALATES AND AROMATIC DIISOCYANATES FROM MONOSACCHARIDES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2026-05-15 WO claimed
US-20260002948-A1 REAGENT FOR DETECTING METHYL SALICYLATE, METHYL SALICYLATE SENSOR, METHOD FOR SENSING METHYL SALICYLATE USING THE SAME, AND METHOD FOR DETECTING PLANT PATHOGEN INFECTION NEC CORPORATION (JP) 2026-01-01 US claimed
US-20250296952-A1 METHOD FOR PREPARING ABIRATERONE ACETATE AND INTERMEDIATE THEREOF AURISCO PHARMACEUTICAL CO., LTD. (CN) 2025-09-25 US claimed
CN-119462574-B 2-Aryl-3-ketiminyl tetrahydrofuran compound, preparation method and application 遵义医科大学 2025-06-13 CN claimed
CN-120118320-A Polyester-based multi-block thermotropic shape memory material with adjustable performance and preparation method thereof 大连理工大学 2025-06-10 CN claimed
CN-120119268-A Synthesis method of chiral 1-tetrahydronaphthalene amide compound 南开大学 2025-06-10 CN claimed
CN-120060873-A Electrochemical synthesis process of iodobenzene diacetic acid 无锡绿能电合科技有限公司 2025-05-30 CN claimed
CN-120073481-A Application of ammonium salt containing acetate in perovskite thin film gain medium 浙江大学 2025-05-30 CN claimed
CN-116239755-B Polyisocyanate composition with high reactivity and preparation method thereof 万华化学集团股份有限公司 2025-05-13 CN claimed
US-20050003206-A1 Solid polyurethane powder coating compositions containing uretdione groups that are hardenable at low temperatures DEGUSSA AG (DE) 2005-01-06 US claimed
CN-1167696-C Preparation method for butyrolactone 巴斯福股份公司 2004-09-22 CN claimed
EP-0758333-B1 INTERMEDIATES IN PHARMACEUTICAL CAMPTOTHECIN PREPARATION OSI PHARM INC (US) 2004-03-03 EP claimed
US-6462005-B1 AQUEOUS SOLUTION CONTAINING A QUARTERNARY AMMONIUM SALT, A FLUORO COMPOUND AND OPTIONALLY AN ORGANIC SOLVENT; PROTECTING DEPOSITION FILM TO BE REMOVED; NO CORROSION OF CONDUCTIVE LAYER BEING DECONTAMINATED TEXAS INSTRUMENTS INCORPORATED 2002-10-08 US claimed
US-6388083-B2 ANTAGONIST TO SUBSTANCE P RECEPTORS MERCK & CO., INC. 2002-05-14 US claimed
US-20020019532-A1 Process for the synthesis of (2S)-phenyl-3-piperidone MERCK & CO., INC. 2002-02-14 US claimed
EP-0758333-A1 INTERMEDIATES IN PHARMACEUTICAL CAMPTOTHECIN PREPARATION GLAXO WELLCOME INC. (US) 1997-02-19 EP claimed
US-5491237-A Intermediates in pharmaceutical camptothecin preparation GLAXO WELLCOME INC. (US) 1996-02-13 US claimed
WO-1995029917-A2 INTERMEDIATES IN PHARMACEUTICAL CAMPTOTHECIN PREPARATION GLAXO WELLCOME INC. (US) 1995-11-09 WO claimed
US-5079098-A Quaternary ammonium compound promoter LOCTITE CORPORATION (US) 1992-01-07 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260002948-A1 REAGENT FOR DETECTING METHYL SALICYLATE, METHYL SALICYLATE SENSOR, METHOD FOR SENSING METHYL SALICYLATE USING THE SAME, AND METHOD FOR DETECTING PLANT PATHOGEN INFECTION PNMT, TRHDE, TBK1 ALDH1A1 3812/4885ATM 407/4885TSHR 163/4885
US-20250296952-A1 METHOD FOR PREPARING ABIRATERONE ACETATE AND INTERMEDIATE THEREOF CYP17A1, CYP21A2, CYP19A1 ALDH1A1 173/4885ATM 1513/4885TSHR 3267/4885
US-20020019532-A1 Process for the synthesis of (2S)-phenyl-3-piperidone DHPS, NPEPPS, ALDH18A1 ALDH1A1 160/4885ATM 4668/4885TSHR 2553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.